Forum Topic Oncology
  • Conversation: Roche launches NGS AVENIO Tumor Tissue Analysis Kits for oncology research

    • October 15, 2018 10:59 PM BST
    • Roche launches NGS AVENIO Tumor Tissue Analysis Kits for oncology research

      Roche today announced the global commercial launch of three new next-generation sequencing (NGS) AVENIO Tumor Tissue Analysis Kits – the AVENIO Tumor Tissue Targeted Kit, Expanded Kit and Surveillance Kit.[1] The kits, which detect all four mutation classes in solid tumours, complement Roche’s NGS ctDNA kits for oncology research. The AVENIO research-use-only (RUO) portfolio of ready-to-use kits provides reagents and software needed for labs to determine the genomic characteristics of solid tumours through a single DNA workflow.
      “With the launch of these innovative assays we are pleased to further empower researchers around the world to continue to advance personalised oncology,” said Michael Heuer, CEO Roche Diagnostics. “These three ready-to-use AVENIO Tumor Tissue Analysis Kits enable researchers by providing relevant panel content that cover all four mutation classes to support the wide variety of cases that require genomic profiling, and complement the previously launched AVENIO ctDNA assays for liquid biopsy.”
      Read more: http://bit.ly/2EiUTbA

Add Reputation

Do you want to add reputation for this member by this post?

or cancel